The tumor infiltrating T cells (both CD4+ and CD8+) of plinabulin-treated mice were functional, with increased capacity to produce intracellular IFN-γ, compared to control (Figure 1G), upon ex vivo re-stimulation with anti-CD3 and anti-CD28 monoclonal antibodies (mAbs). Here, CD8A is linked to neoplasm.